These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 26568586

  • 21. Autoimmune hepatitis in 847 childhood-onset systemic lupus erythematosus population: a multicentric cohort study.
    Balbi VA, Montenegro B, Pitta AC, Schmidt AR, Farhat SC, Coelho LP, Ferreira JCO, Pereira RMR, Terreri MT, Saad-Magalhães C, Aikawa NE, Sakamoto AP, Kozu K, Campos LM, Sallum AM, Ferriani VP, Piotto DP, Bonfá E, Silva CA.
    Adv Rheumatol; 2018 Dec 13; 58(1):43. PubMed ID: 30657090
    [Abstract] [Full Text] [Related]

  • 22. Impact of follow-up adherence on disease activity in childhood-onset systemic lupus erythematosus (cSLE).
    Nelson MC, Mosley C, Villacis-Nunez DS, Rouster-Stevens K, Thakral A.
    Lupus; 2023 May 13; 32(6):799-803. PubMed ID: 37125694
    [Abstract] [Full Text] [Related]

  • 23. Disease presentation of 1312 childhood-onset systemic lupus erythematosus: influence of ethnicity.
    Fiorot FJ, Islabão AG, Pereira RM, Terreri MT, Saad-Magalhães C, Novak GV, Molinari BC, Sakamoto AP, Aikawa NE, Campos LM, Peracchi OA, Appenzeller S, Ferriani VP, Silva MF, Fonseca AR, Sztajnbok FR, Paim LB, Fraga MM, Okuda EM, Bica BE, Sena EG, Moraes AJ, Rolim AM, Spelling PF, Scheibel IM, Cavalcanti AS, Matos EN, Robazzi TC, Guimarães LJ, Santos FP, Ramos VC, Carneiro-Sampaio M, Bonfá E, Silva CA, Brazilian Childhood-onset Systemic Lupus Erythematosus Group.
    Clin Rheumatol; 2019 Oct 13; 38(10):2857-2863. PubMed ID: 31209708
    [Abstract] [Full Text] [Related]

  • 24. Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.
    Sousa S, Gonçalves MJ, Inês LS, Eugénio G, Jesus D, Fernandes S, Terroso G, Romão VC, Cerqueira M, Raposo A, Couto M, Nero P, Sequeira G, Nóvoa T, Melo Gomes JA, da Silva JC, Costa L, Macieira C, Silva C, Silva JA, Canhão H, Santos MJ.
    Rheumatol Int; 2016 Jul 13; 36(7):955-60. PubMed ID: 26979603
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
    Arthritis Care Res (Hoboken); 2013 Jul 13; 65(7):1121-7. PubMed ID: 23818263
    [Abstract] [Full Text] [Related]

  • 27. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
    Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, Kasapcopur O.
    Lupus; 2017 Sep 13; 26(10):1089-1094. PubMed ID: 28420068
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain RJEM, Zirkzee E, Fritsch-Stork R, Bultink IEM, Kamphuis S.
    Arthritis Rheumatol; 2019 Feb 13; 71(2):290-301. PubMed ID: 30152151
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus.
    Sinicato NA, Postal M, de Oliveira Peliçari K, Rittner L, Marini R, Appenzeller S.
    Clin Rheumatol; 2017 Jul 13; 36(7):1527-1535. PubMed ID: 28424906
    [Abstract] [Full Text] [Related]

  • 32. Pancreatitis Subtypes Survey in 852 Childhood-Onset Systemic Lupus Erythematosus Patients.
    Marques VL, Gormezano NW, Bonfá E, Aikawa NE, Terreri MT, Pereira RM, Magalhães CS, Guariento A, Appenzeller S, Ferriani VP, Barbosa CM, Ramos VC, Lotufo S, Silva CA.
    J Pediatr Gastroenterol Nutr; 2016 Feb 13; 62(2):328-34. PubMed ID: 26418213
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan.
    Weng CT, Lee NY, Liu MF, Weng MY, Wu AB, Chang TW, Lin TS, Wang JY, Chang HY, Wang CR.
    Lupus; 2010 Sep 13; 19(10):1204-9. PubMed ID: 20515999
    [Abstract] [Full Text] [Related]

  • 35. Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study.
    Cavalcanti A, Santos R, Mesquita Z, Duarte AL, Lucena-Silva N.
    Braz J Med Biol Res; 2017 Apr 03; 50(4):e5738. PubMed ID: 28380214
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB, Bae SC.
    Int J Rheum Dis; 2015 Feb 03; 18(2):117-28. PubMed ID: 25524656
    [Abstract] [Full Text] [Related]

  • 38. Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients.
    Gormezano NW, Silva CA, Aikawa NE, Barros DL, da Silva MA, Otsuzi CI, Kozu K, Seguro LP, Pereira RM, Bonfá E.
    Clin Rheumatol; 2016 Jan 03; 35(1):227-31. PubMed ID: 26615611
    [Abstract] [Full Text] [Related]

  • 39. Anti-ribosomal P antibody: a multicenter study in childhood-onset systemic lupus erythematosus patients.
    Valões CC, Molinari BC, Pitta AC, Gormezano NW, Farhat SC, Kozu K, Sallum AM, Appenzeller S, Sakamoto AP, Terreri MT, Pereira RM, Magalhães CS, Ferreira JC, Barbosa CM, Gomes FH, Bonfá E, Silva CA, Brazilian Childhood-onset Systemic Lupus Erythematosus Group.
    Lupus; 2017 Apr 03; 26(5):484-489. PubMed ID: 28394238
    [Abstract] [Full Text] [Related]

  • 40. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
    De la Serna J, Jarque I, López-Jiménez J, Fernández-Navarro JM, Gómez V, Jurado M, Pascual A, Serrano J, Romero M, Vallejo C.
    Rev Esp Quimioter; 2013 Mar 03; 26(1):64-9. PubMed ID: 23546466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.